Enrofloxacin 50 mg/ml

Cattle

Calves: Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of Pasteurella multocida, Mannheimia haemolytica  and Mycoplasma  spp. 
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of Escherichia coli. 
Treatment of septicaemia caused by enrofloxacin susceptible strains of Escherichia coli;. 
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of Mycoplasma bovis.

Calves: Intravenous or subcutaneous route. 
5 mg enrofloxacin/kg b.w. /day (corresponding to 1 ml/10 kg b.w./day), for 3-5 days.

Calves: Meat and offal: 5 days (IV route), 12 days (SC route).
Not authorised for use in animals producing milk for human consumption.

Pigs

Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of Pasteurella multocida, Mycoplasma spp. and Actinobacillus pleuropneumoniae.
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of Escherichia coli. 

Intramuscular route.
2.5 mg of enrofloxacin/kg b.w./day (corresponding to 0.5 ml/10 kg b.w./day), for 3 days.
Alimentary tract infection or septicaemia caused by Escherichia coli: 5 mg of enrofloxacin/kg b.w./day (corresponding to 1 ml/10 kg b.w./day), for 3 days.

Meat and offal: 13 days.

Sheep

Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of mastitis caused by enrofloxacin susceptible strains of Staphylococcus aureus and Escherichia coli.

Subcutaneous route.
5 mg enrofloxacin/kg b.w./day (corresponding to 1 ml/10 kg b.w./day), for 3 days.

Meat and offal: 4 days.
Milk: 3 days.

Dogs

Treatment of infections of the alimentary, respiratory and urogenital tracts (including prostatitis, adjunctive antibiotic therapy for pyometra), skin and wound infections, otitis (externa/media) caused by enrofloxacin susceptible strains of Staphylococcus spp., Escherichia coli, Pasteurella spp., Klebsiella spp., Bordetella spp., Pseudomonas spp. and Proteus spp.

Subcutaneous route.
5 mg of enrofloxacin/kg b.w./day (corresponding to 1 ml/10 kg b.w./day), for up to 5 days.

Cats

Treatment of infections of the alimentary, respiratory and urogenital tracts (as adjunctive antibiotic therapy for pyometra), skin and wound infections, caused by enrofloxacin susceptible strains of, e.g.:
Staphylococcus spp., Escherichia coli, Pasteurella spp., Klebsiella spp., Bordetella spp., Pseudomonas spp. and Proteus spp.

Subcutaneous route.
5 mg of enrofloxacin/kg b.w./day (corresponding to 1 ml/10 kg b.w./day), for up to 5 days.

Goats

Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of Pasteurella multocida and Mannheimia haemolytica.
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of mastitis caused by enrofloxacin susceptible strains of Staphylococcus aureus and Escherichia coli.

Subcutaneous route.
5 mg enrofloxacin/kg b.w./day (corresponding to 1 ml/10 kg b.w./day), for 3 days.

Meat and offal: 6 days.
Milk: 4 days.

Vial of 100 ml